Trial intelligence / Profile preview

Droxidopa for Freezing of Gait in Parkinson's Disease

NCT02066571Phase 2Unknown

Sponsor
Henry Ford Health
Start
Mar 2015
Primary completion
Apr 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of droxidopa in Parkinson's disease (PD), sponsored by Henry Ford Health. Status: unknown.

02

Drugs

droxidopa
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT02066571.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02066571.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call